444 participants
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-20
- Start Date:
- 2019-03-07
- Completion:
- 2020-06-22
Conditions
- Psoriatic Arthritis (PsA)
Interventions
- BIOLOGICAL